Evidence map›Paper›PMID 39680349›Full record

ArticleInternational journal of hematology2025

A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02.

Hironori Arai, Naoko Hosono, SungGi Chi, Kentaro Fukushima, Daisuke Ikeda, Satoshi Iyama, Akihiko Gotoh, Takayuki Ikezoe, Chikashi Yoshida, Goichi Yoshimoto and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hironori Arai *Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan.
Naoko Hosono *Department of Hematology and Oncology, University of Fukui, Fukui, Japan.
SungGi Chi *Department of Hematology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan.
Kentaro FukushimaOsaka University Graduate School of Medicine, Suita, Japan.
Daisuke IkedaDivision of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, Japan.
Satoshi IyamaDepartment of Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Akihiko GotohDepartment of Hematology, Tokyo Medical University, Tokyo, Japan.
Takayuki IkezoeKochi University, Nankoku, Japan.
Chikashi YoshidaNHO Mito Medical Center, Ibaraki, Japan.
Goichi YoshimotoSaga-Ken Medical Center Koseikan, Saga, Japan.
Junya KandaDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Naoto TakahashiDepartment of Hematology, Nephrology and Rheumatology, Akita University, Akita, Japan.
Emiko SakaidaDepartment of Hematology, Chiba University Hospital, Chiba City, Japan.
Kensuke UsukiDepartment of Hematology, NTT Medical Center Tokyo, Shinagawa-Ku, Japan.
Takahiro YamauchiDepartment of Hematology and Oncology, University of Fukui, Fukui, Japan.
Yosuke MinamiDepartment of Hematology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan. yominami@east.ncc.go.jp.ORCID http://orcid.org/0000-0003-0863-0739

Funding

National Cancer Center 2021-A-11
6 · The paper itself

Abstract

HM-SCREEN-Japan is a multicenter collaborative project in Japan to evaluate the clinical utility of a cancer genome panel in the treatment of acute myeloid leukemia (AML). The HM-SCREEN-JAPAN02 study used the Amoy Myeloid Panel

Indexed as

Genetic TestingLeukemia, Myeloid, AcuteAdultAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedMutationAcute myeloid leukemiaGenomic testingNext-generation sequencing

Identifiers

PMID39680349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.